Your browser doesn't support javascript.
loading
Assessment of Five-Year Relative Survival of Patients With Endometrial Cancer: A Period Analysis.
Zhao, Xiao Jiao; Bing, Xin; Lei, Qi Qi; Cheng, Yong Ran; Yang, Jun; Wang, Liang You; Chen, Tian Hua; Chen, Tian Hui.
Afiliação
  • Zhao XJ; Department of Medical Insurance, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  • Bing X; These authors contributed equally to this work.
  • Lei QQ; Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou 310022, China.
  • Cheng YR; School of Public Health, Hangzhou Normal University, Hangzhou 311121, China.
  • Yang J; These authors contributed equally to this work.
  • Wang LY; Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou 310022, China.
  • Chen TH; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310018, China.
  • Chen TH; School of Public Health, Hangzhou Medical College, Hangzhou, China.
World J Oncol ; 15(5): 784-791, 2024 Oct.
Article em En | MEDLINE | ID: mdl-39328326
ABSTRACT

Background:

Endometrial cancer is one of the most common female cancers globally and in China. Although timely assessment of 5-year relative survival is crucial for guiding secondary prevention and early screening programs for endometrial cancer patients, those kinds of data are scarce in China. We aimed to provide a timely and accurate assessment of 5-year relative survival for patients with endometrial cancer from eastern China.

Methods:

Overall, 945 patients diagnosed with endometrial cancer during 2004 - 2018 from four cancer registries with high-quality data from Taizhou, eastern China were included. Period analysis was used to calculate 5-year relative survival for overall and the stratification by age at diagnosis and region. Model-based period analysis was used to predict the 5-year relative survival for the upcoming period of 2019 - 2023.

Results:

We found that 5-year relative survival during 2014 - 2018 reached 86.4% for overall, while urban areas had higher survival compared to rural areas (91.3% vs. 85.3%). Furthermore, there was a clear age gradient, decreasing from 89.3% for age < 55 years to 80.5% for age > 74 years. Predicted 5-year relative survival for the upcoming period 2019 - 2023 could reach 88.4%.

Conclusions:

We provide, a timely and accurate assessment of 5-year relative survival for patients with endometrial cancer from Taizhou, eastern China, reaching 86.4% for overall. Our finding has important implications for the overall evaluation of early detection and screening programs for patients with endometrial cancer in eastern China.
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Canadá
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Canadá